Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $143,449 | 43 | 81.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,925 | 6 | 9.6% |
| Travel and Lodging | $9,609 | 23 | 5.5% |
| Food and Beverage | $5,357 | 82 | 3.1% |
| Education | $112.29 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $45,036 | 51 | $0 (2021) |
| TOPCON CORPORATION | $43,719 | 4 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $36,752 | 38 | $0 (2021) |
| Alcon Vision LLC | $8,259 | 15 | $0 (2024) |
| Genentech, Inc. | $7,562 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $7,038 | 6 | $0 (2018) |
| ABBVIE INC. | $6,783 | 4 | $0 (2024) |
| Janssen Research & Development, LLC | $6,188 | 1 | $0 (2022) |
| Carl Zeiss Meditec, Inc. | $3,527 | 4 | $0 (2024) |
| Alcon Research Ltd | $3,420 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,491 | 9 | Alcon Vision LLC ($3,198) |
| 2023 | $4,697 | 5 | Alcon Vision LLC ($2,997) |
| 2022 | $14,683 | 7 | ABBVIE INC. ($6,615) |
| 2021 | $6,711 | 12 | Genentech, Inc. ($3,781) |
| 2020 | $15,407 | 4 | Allergan, Inc. ($10,106) |
| 2019 | $37,615 | 47 | Allergan Inc. ($21,184) |
| 2018 | $35,746 | 41 | Aerie Pharmaceuticals, Inc. ($21,501) |
| 2017 | $55,102 | 31 | TOPCON CORPORATION ($40,000) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Ophthalmology | ||||||
| 10/20/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $126.07 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: EYE CARE | ||||||
| 07/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: EYE CARE | ||||||
| 05/28/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2024 | Carl Zeiss Meditec, Inc. | PRESBYOND (Device), RESCAN 700, VERACITY SURGICAL | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Surgical Optical Laser | ||||||
| 03/07/2024 | Alcon Vision LLC | Rhopressa (Drug), Rocklatan, Simbrinza | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| Category: Ophthalmology | ||||||
| 02/29/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $142.33 | General |
| Category: Ophthalmology | ||||||
| 02/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: EYE CARE | ||||||
| 08/07/2023 | Carl Zeiss Meditec, Inc. | FORUM (Device), FORUM Glaucoma Workplace, Humphrey HFA | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Eye Care Data Management | ||||||
| 07/20/2023 | Alcon Vision LLC | Simbrinza (Drug), Rhopressa | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Ophthalmology | ||||||
| 06/23/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Ophthalmology | ||||||
| 06/07/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $146.98 | General |
| Category: Ophthalmology | ||||||
| 04/23/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $50.50 | General |
| Category: Ophthalmology | ||||||
| 10/21/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Travel and Lodging | Cash or cash equivalent | $21.00 | General |
| Category: Ophthalmology | ||||||
| 10/21/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Travel and Lodging | Cash or cash equivalent | $17.10 | General |
| Category: Ophthalmology | ||||||
| 10/07/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Consulting Fee | Cash or cash equivalent | $1,710.00 | General |
| Category: Ophthalmology | ||||||
| 09/29/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $50.24 | General |
| Category: Ophthalmology | ||||||
| 06/16/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $6,187.50 | General |
| 04/29/2022 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $82.43 | General |
| Category: Ophthalmology | ||||||
| 04/21/2022 | ABBVIE INC. | DURYSTA (Drug) | Consulting Fee | Cash or cash equivalent | $6,615.00 | General |
| Category: GLAUCOMA | ||||||
| 12/12/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | Cash or cash equivalent | $48.21 | General |
| Category: GLAUCOMA | ||||||
| 12/12/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | Cash or cash equivalent | $38.44 | General |
| Category: GLAUCOMA | ||||||
| 12/12/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | Cash or cash equivalent | $33.24 | General |
| Category: GLAUCOMA | ||||||
| 12/11/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | Cash or cash equivalent | $66.48 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 5,671 | 7,727 | $3.5M | $501,270 |
| 2022 | 20 | 5,465 | 8,021 | $3.9M | $539,552 |
| 2021 | 22 | 5,716 | 7,979 | $4.4M | $610,604 |
| 2020 | 21 | 4,661 | 5,854 | $3.0M | $417,145 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 1,181 | 1,958 | $685,300 | $143,272 | 20.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 1,343 | 2,069 | $826,880 | $107,323 | 13.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 1,269 | 1,736 | $451,360 | $48,308 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 355 | $188,150 | $41,188 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 369 | 385 | $146,300 | $31,281 | 21.4% |
| 66170 | Creation of eye fluid drainage tract for treatment of glaucoma | Facility | 2023 | 20 | 21 | $203,910 | $20,987 | 10.3% |
| 66180 | Creation of shunt to improve eye fluid flow using tissue graft | Facility | 2023 | 19 | 20 | $189,000 | $20,786 | 11.0% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 64 | 75 | $207,750 | $16,325 | 7.9% |
| 92250 | Photography of the retina | Office | 2023 | 431 | 453 | $212,910 | $13,214 | 6.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 105 | 106 | $47,700 | $11,586 | 24.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 70 | 70 | $37,100 | $8,660 | 23.3% |
| 66250 | Revision or repair of operative wound of eye | Office | 2023 | 11 | 11 | $68,310 | $6,915 | 10.1% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 16 | 25 | $60,500 | $6,628 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $23,760 | $5,560 | 23.4% |
| 66250 | Revision or repair of operative wound of eye | Facility | 2023 | 12 | 12 | $74,520 | $5,203 | 7.0% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 70 | 70 | $25,200 | $4,839 | 19.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 194 | 195 | $31,200 | $4,405 | 14.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $12,580 | $2,808 | 22.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 18 | 25 | $10,800 | $894.89 | 8.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 71 | 71 | $10,650 | $635.67 | 6.0% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 16 | 17 | $3,460 | $453.01 | 13.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 1,273 | 2,577 | $901,950 | $192,877 | 21.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 1,389 | 2,113 | $844,960 | $113,562 | 13.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 1,252 | 1,704 | $443,040 | $49,565 | 11.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 257 | 263 | $118,350 | $26,632 | 22.5% |
About Dr. Jeffrey Liebmann, MD
Dr. Jeffrey Liebmann, MD is a Glaucoma Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033199450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Liebmann, MD has received a total of $175,452 in payments from pharmaceutical and medical device companies, with $5,491 received in 2024. These payments were reported across 156 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($143,449).
As a Medicare-enrolled provider, Liebmann has provided services to 21,513 Medicare beneficiaries, totaling 29,581 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Glaucoma Specialist
- Other Specialties Ophthalmology
- Location New York, NY
- Active Since 01/20/2006
- Last Updated 02/19/2018
- Taxonomy Code 207WX0009X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033199450
Products in Payments
- OCT (Device) $40,000
- Rhopressa (Drug) $22,541
- DURYSTA (Drug) $19,641
- Rocklatan (Drug) $13,764
- XEN (Device) $10,345
- HYDRUS Microstent (Device) $6,128
- OCT-TRITON (Device) $4,084
- CyPass (Device) $3,420
- TRAVATAN Z (Drug) $1,888
- FORUM (Device) $1,700
- PRESBYOND (Device) $1,700
- OCT-MAESTRO (Device) $1,500
- LOTEMAX GEL (Drug) $1,023
- Simbrinza (Drug) $700.00
- IYUZEH (Drug) $425.00
- Centurion (Device) $211.77
- AcrySof (Device) $200.30
- ACTIVEFOCUS (Device) $149.97
- MACUGEN (Drug) $140.37
- rocklatan (Drug) $127.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Glaucoma Specialist Doctors in New York
Sarah Vantassel, Md, MD
Glaucoma Specialist — Payments: $66,165
Dr. Yuna Rapoport, M.d, M.D
Glaucoma Specialist — Payments: $50,022
Aakriti Shukla, M.d, M.D
Glaucoma Specialist — Payments: $41,163
Dr. Sonya Dhar, Md, MD
Glaucoma Specialist — Payments: $20,404
Luis Silva Alvarez, M.d, M.D
Glaucoma Specialist — Payments: $7,831
Varun Reddy
Glaucoma Specialist — Payments: $4,649